Tirzepatide × Hydro Research Peptides - Lab Test, July 2025
Test results
About this test
This independent lab test confirms Tirzepatide (T60) from Hydro Research Peptides at 99.908% purity. The analysis was conducted by Janoshik Labs on July 30, 2025. The tested sample contained 63.46mg of the stated peptide compound.
Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for its role in metabolic regulation, weight management, and glycemic control. Studies indicate potential applications in type 2 diabetes management and obesity research. A purity level of 99.908% indicates exceptional high-grade synthesis with minimal contamination.
The full certificate of analysis is available for verification at www.janoshik.com/verify/ using the unique key RF6CANJD2LH3.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.